Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 6 (2009), Issue 5 (May)

1. Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma.
   Cancer Chemother Pharmacol, 64(1): 161-7. [Abstract] [Full-text]
2. Long-term response of isolated limb perfusion with hyperthermia and chemotherapy for Merkel cell carcinoma.
   Eur J Surg Oncol, 35(6): 568-72. [Abstract] [Full-text]
3. Fiber diffraction of skin and nails provides an accurate diagnosis of malignancies.
   Int J Cancer, 125(1): 133-8. [Abstract] [Full-text]
4. Merkel cell carcinoma in a child.
   J Pediatr Hematol Oncol, 31(5): 359-61. [Abstract] [Full-text]
5. Plasmacytoid dendritic cell leukemia in children.
   J Pediatr Hematol Oncol, 31(5): 339-43. [Abstract] [Full-text]
6. Major amputation for irresectable extremity melanoma after failure of isolated limb infusion.
   Ann Surg Oncol, 16(6): 1543-7. [Abstract] [Full-text]
7. Age-related lymphatic dysfunction in melanoma patients.
   Ann Surg Oncol, 16(6): 1548-52. [Abstract] [Full-text]
8. The yield of SPECT/CT for anatomical lymphatic mapping in patients with melanoma.
   Ann Surg Oncol, 16(6): 1537-42. [Abstract] [Full-text]
9. Surgical management of melanoma-in-situ using a staged marginal and central excision technique.
   Ann Surg Oncol, 16(6): 1526-36. [Abstract] [Full-text]
10. Stem cells in melanoma development.
    Cancer Lett, 279(2): 119-25. [Abstract] [Full-text]
11. Single nucleotide polymorphism array analysis defines a specific genetic fingerprint for well-differentiated cutaneous SCCs.
    J Invest Dermatol, 129(6): 1562-8. [Abstract] [Full-text]
12. Frequencies of NRAS and BRAF mutations increase from the radial to the vertical growth phase in cutaneous melanoma.
    J Invest Dermatol, 129(6): 1483-8. [Abstract] [Full-text]
13. Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc.
    J Invest Dermatol, 129(6): 1547-55. [Abstract] [Full-text]
14. Comparison of interventions to reduce sun exposure.
    Behav Med, 35(2): 67-76. [Abstract] [Full-text]
15. Extranodal nasal-type natural killer/T-cell lymphoma of the skin: a clinicopathologic study of 16 cases in China.
    Hum Pathol, 40(6): 807-16. [Abstract] [Full-text]
16. Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b).
    Mol Carcinog, 48(6): 508-16. [Abstract] [Full-text]
17. Reconstruction of full-thickness calvarial defect: a role for artificial dermis.
    Ann Plast Surg, 62(6): 656-9. [Abstract] [Full-text]
18. Percentage of {gamma}{delta} T cells in panniculitis by paraffin immunohistochemical analysis.
    Am J Clin Pathol, 131(6): 820-6. [Abstract] [Full-text]
19. Cutaneous peripheral T-cell lymphoma associated with a proliferation of B cells.
    Am J Clin Pathol, 131(6): 810-9. [Abstract] [Full-text]
20. Protein expression of carcinoembryonic antigen cell adhesion molecules in benign and malignant melanocytic skin lesions.
    Am J Clin Pathol, 131(6): 782-7. [Abstract] [Full-text]
21. Erbb2 suppresses DNA damage-induced checkpoint activation and UV-induced mouse skin tumorigenesis.
    Am J Pathol, 174(6): 2357-66. [Abstract] [Full-text]
22. Secretory carcinoma in the axilla: probable origin from axillary skin appendage glands in a young girl.
    Am J Surg Pathol, 33(6): 950-3. [Abstract] [Full-text]
23. Neurothekeoma and plexiform fibrohistiocytic tumor: mere histologic resemblance or histogenetic relationship?
    Am J Surg Pathol, 33(6): 905-13. [Abstract] [Full-text]
24. Dermatofibrosarcoma protuberans in children.
    J Plast Reconstr Aesthet Surg, 62(6): 819-23. [Abstract] [Full-text]
25. Case study: the surgical management of angiokeratoma resulting from radiotherapy for penile cancer.
    ScientificWorldJournal, 9: 339-42. [Abstract] [Full-text]
26. A case of recurrent pseudolymphomatous folliculitis: A mimic of cutaneous lymphoma.
    J Am Acad Dermatol, 60(6): 994-1000. [Abstract] [Full-text]
27. The inadequacy of punch-excised melanocytic lesions: sampling through the block for the determination of "margins".
    J Am Acad Dermatol, 60(6): 990-3. [Abstract] [Full-text]
28. Incidence of nonmelanoma skin cancer in a cohort of patients with vitiligo.
    J Am Acad Dermatol, 60(6): 929-33. [Abstract] [Full-text]
29. Treatments for psoriasis and the risk of malignancy.
    J Am Acad Dermatol, 60(6): 1001-17. [Abstract] [Full-text]
30. Immunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patients.
    Cancer Immunol Immunother, 58(8): 1265-73. [Abstract] [Full-text]
31. Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases.
    Cancer Immunol Immunother, 58(8): 1297-306. [Abstract] [Full-text]
32. Small margin excision of periocular basal cell carcinomas.
    Br J Ophthalmol, 93(6): 803-6. [Abstract] [Full-text]
33. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases.
    Blood, 113(21): 5064-73. [Abstract] [Full-text]
34. Multiple intracranial melanoma metastases: case report and review of the literature.
    J Neurooncol, 93(3): 413-20. [Abstract] [Full-text]
35. Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy.
    J Clin Oncol, 27(16): 2645-52. [Abstract] [Full-text]

© 2004-2012 Skin Cancer Research Today. All Rights Reserved.